Antimicrobial Locks: Putting the Lock on Catheter Infections

Advances in Chronic Kidney Disease

Volumn 13, Issue 3, 2006, Pages 245-258

  Manierski, Carol ^a   Besarab, Anatole ^a  

^a HENRY FORD HEALTH SYSTEM   (United States)

Author keywords

Antibiotic lock; Antimicrobial lock; Catheter related bacteremia; Lock solution

Indexed keywords

ANTIINFECTIVE AGENT; CEFAZOLIN; CEFTAZIDIME; CIPROFLOXACIN; CITRATE TRISODIUM; EDETIC ACID; GENTAMICIN; HEPARIN; MINOCYCLINE; TAUROLIDINE; VANCOMYCIN;

ANTIBIOTIC THERAPY; ANTIMICROBIAL ACTIVITY; ARTICLE; ATAXIA; BACTEREMIA; BACTERIAL COLONIZATION; BACTERIAL SURVIVAL; BACTERIUM ADHERENCE; BACTERIUM CULTURE; BIOFILM; CANDIDIASIS; CATHETER INFECTION; CATHETER REMOVAL; CLINICAL TRIAL; COAGULASE NEGATIVE STAPHYLOCOCCUS; CONCENTRATION RESPONSE; DIZZINESS; DRUG BLOOD LEVEL; DRUG EFFICACY; HEARING IMPAIRMENT; HEMODIALYSIS; HEPARINIZATION; HUMAN; INFECTION COMPLICATION; INSTRUMENT STERILIZATION; INTRAVASCULAR CATHETER; LOW DRUG DOSE; MICROBIAL GROWTH; MORBIDITY; MORTALITY; OTOTOXICITY; PRACTICE GUIDELINE; PRIORITY JOURNAL; SEPSIS; SIDE EFFECT; SKIN FLORA; STAPHYLOCOCCUS EPIDERMIDIS; THROMBOCYTOPENIA; THROMBOSIS; TOTAL PARENTERAL NUTRITION; TREATMENT FAILURE; VASCULAR ACCESS;

ANTI-BACTERIAL AGENTS; BACTEREMIA; CATHETERS, INDWELLING; HUMANS; PROSTHESIS-RELATED INFECTIONS; RENAL DIALYSIS; TREATMENT OUTCOME;

EID: 33745354751     PISSN: 15485595     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.ackd.2006.04.003     Document Type: Article

References (64)

1. Blankestijn P.J. Treatment and prevention of catheter-related infections in haemodialysis patients. Nephrol Dial Transplant 16 (2001) 1975-1978
2. Sarnak M.J., and Jaber B.L. Mortality caused by sepsis in patients with end-stage renal disease compared with the general population. Kidney Int 58 (2000) 1758-1764
3. Tokars J.I., Miller E.R., and Stein G. New national surveillance system for hemodialysis-associated infections. Initial results. Am J Infect Control 30 (2002) 288-295
4. Dhingra R.K., Young E.W., Hulbert-Shearon T.E., et al. Type of vascular access and mortality in U.S. hemodialysis patients. Kidney Int 60 (2001) 1443-1451
5. Ishani A., Collins A.J., Herzog C.A., et al. Septicemia, access and cardiovascular disease in dialysis patients. The USRDS Wave 2 study. Kidney Int 68 (2005) 311-318
6. Lee T., Barker J., and Allon M. Tunneled catheters in hemodialysis patients. Reasons and subsequent outcomes. Am J Kidney Dis 46 (2005) 501-508
7. USRDS data. http://www.usrds.org/atlas.htm
8. Rayner H.C., Besarab A., Brown W.W., et al. Vascular access results from the Dialysis Outcomes and Practice Patterns Study (DOPPS). Performance against Kidney Disease Outcomes Quality Initiative (K/DOQI) Clinical Practice Guidelines. Am J Kidney Dis 44 suppl 3 (2004) 22-26
9. Taylor G., Gravel D., Johnston L., et al. Prospective surveillance for primary bloodstream infections occurring in Canadian hemodialysis units. Infect Control Hosp Epidemiol 23 (2002) 716-720
10. Jean G., Charra B., Chazot C., et al. Risk factor analysis for long-term tunneled dialysis catheter-related bacteremias. Nephron 91 (2002) 399-405
11. Zaleski G.X., Funaki B., Lorenz J.M., et al. Experience with tunneled femoral hemodialysis catheters. Am J Roentgenol 172 (1999) 493-496
12. Saxena A.K., Panhorota B.R., and Al-Mulhim A.S. Vascular Access related infections in hemodialysis patients. Saudi J Kidney Dis Transplant 16 (2005) 46-71
13. Beathard G.A., and Posen G.A. Initial clinical results with the lifesite hemodialysis access system. Kidney Int 58 (2000) 2221-2227
14. Dogra G.K., Herson H., Hutchison B., et al. Prevention of tunneled hemodialysis catheter-related infections using catheter-restricted filling with gentamicin and citrate. A randomized controlled study. J Am Soc Nephrol 13 (2002) 2133-2139
15. Tokars J.L., Light P., Anderson J., et al. A prospective study of vascular access infections at seven outpatient hemodialysis centers. Am J Kidney Dis 37 (2001) 1232-1240
16. Engemann J.J., Friedman J.Y., Reed S.D., et al. Clinical outcomes and costs due to Staphylococcus aureus bacteremia among patients receiving long-term hemodialysis. Infect Control Hosp Epidemiol 26 (2005) 534-539
17. Messing B., Peitra-Cohen S., Beliah M., and Bernier J. Antibiotic-lock technique. An approach to iptimal therapy for catheter-related sepsis in home parenteral nutrition patients. JPEN J Parenter Enteral Nutr 12 (1988) 185
18. Dasgupta M.K. Biofilms and infection in dialysis patients. Semin Dial 15 (2002) 338-346
19. Raad I., Costerton W., Sabharwal U., et al. Ultrastructural analysis of indwelling vascular catheters. A quantitative relationship between luminal colonization and duration of placement. J Infect Dis 168 (1993) 400-407
20. Maar K.A., Sexton D.J., Conlon P.J., et al. Catheter-related bacteraemia and outcome of attempted catheter salvage in patients undergoing haemodialysis. Ann Intern Med 15 (1998) 275-280
21. Mohammad S.F. Enhanced risk of infection with device-associated thrombi. ASAIO J 46 suppl (2000) S63-S68
22. Costerton J.W., Stewart P.S., and Greenberg E.P. Bacterial biofilms. A common cause of persistent infection. Science 284 (1999) 1318-1322
23. Yasuda H., Ajiki Y., Aoyama J., et al. Interaction between human polymorphonuclear leucocytes and bacteria released from in-vitro bacterial biofilm models. J Med Microbiol 41 (1994) 359-367
24. Andris D.A., Krzywda E.A., Edmiston C.E., et al. Elimination of intraluminal colonization by antibiotic lock in silicone vascular catheters. Nutrition 14 (1998) 427-432
25. Gaillard J.L., Merlino R., Pajot N., et al. Conventional and nonconventional modes of vancomycin administration to decontaminate the internal surface of catheters colonized with coagulase-negative staphylococci. JPEN J Parenter Enteral Nutr 14 (1990) 593-597
26. Simon V.C., and Simon M. Antibacterial activity of teicoplanin and vancomycin in combination with rifampicin, fusidic acid, or fosfomycin against staphylococci on vein catheters. Scand J Infect Dis 72 suppl (1990) 14-19
27. Guggenbichler J.P., Berchtold D., Allerberger F.R., et al. In vitro and in vivo effect on antibiotics on catheters colonized by staphylococci. Eur J Clin Microbiol Infect Dis 11 (1992) 408-415
28. Kropec A., Huebner J., Wursthorn M., et al. In vitro activity of vancomycin and teicoplanin against Staphylococcus epidermidis colonizing catheters. Eur J Clin Microbiol Infect Dis 12 (1993) 545-548
29. De Arellano E.R., Pascual A., Martinez-Martinez L., et al. Activity of eight antibacterial agents on Staphylococcus epidermidis attached to Teflon catheters. J Med Microbiol 40 (1994) 43-47
30. Pascual A., Arellano E.R., Martinez-Martinez L., et al. Effect of polyurethane catheters and bacterial biofilms on the in-vitro activity of antimicrobials against Staphylococcus epidermidis. J Hosp Infect 24 (1993) 211-218
31. Bastani B., Minton J., and Islam S. Insufficient penetration of systemic vancomycin into the PermCath lumen. Nephrol Dial Transplant 15 (2000) 1035-1037
32. Gaillard J.L., Merlino R., Pajo N., et al. Conventional and nonconventional modes of vancomycin administration to decontaminate the internal surface of catheters colonized with coagulase-negative staphylococci. JPEN J Parenter Enteral Nutr 14 (1990) 593-597
33. Regamy C., Schaverg D., and Kirby W.M. Inhibitory effect of heparin on gentamicin concentrations in blood. Antimicrob Agents Chemother 1 (1972) 329-332
34. Krishnasami Z., Carlton D., Bimbo L., et al. Management of hemodialysis catheter-related bacteremia with an adjunctive antibiotic lock solution. Kidney Int 61 (2002) 1136-1142
35. Torres-Viera C., Thauvin-Eliopoulos C., Souli M., et al. Activities of taurolidine in vitro and in experimental enterococcal endocarditis. Antimicrob Agents Chemother 44 (2000) 1720-1724
36. Capdevila J.A., Gavalda J., Fortea J., et al. Lack of antimicrobials activity of sodium heparin for treating experimental catheter-related infection due to Staphylococcus aureus using the antibiotic-lock technique. Clin Microbiol Infect 7 (2001) 206-212
37. Shanks R.M.Q., Donegan N.P., Graber M.L., et al. Heparin stimulates Staphylococcus aureus biofilm formation. Infect Immun 73 (2005) 4596-4606
38. Weijmer M.C., Debets-Ossenkopp Y.J., Vondervoort F.J., et al. Superior antimicrobial activity of trisodium citrate over heparin for catheter locking. Nephrol Dial Transplant 17 (2002) 2189-2195
39. FDA News Page. FDA Issues Warning on Tricitrasol. April 14, 2000
40. Vercaigne L.M., Sitar D.S., Penner S.B., et al. Antibiotic-Heparin lock. in vitro antibiotic stability combined with heparin in a central venous catheter. Pharmacotherapy 20 (2000) 394-399
41. Riley B.B. Incompatibilities in intravenous solution. J Hosp Pharm 28 (1970) 228-240
42. McIntyre C.W., Hulme L.J., Taal M., et al. Locking of tunneled hemodialysis catheters with gentamicin and heparin. Kidney Int 66 (2004) 801-805
43. Bastani B., Amin K., and Herr A. Prolonged stability of stored vancomycin, gentamicin, and heparin for use in the antibiotic-lock technique. ASAIO J 51 (2005) 761-763
44. Boorgu R., Dubrow A.J., Levin N.W., et al. Adjunctive antibiotic/anticoagulant lock therapy in the treatment of bacteremia associated with the use of a subcutaneously implanted hemodialysis access device. ASAIO J 46 (2000) 767-770
45. Haimi-Cohen Y., Husain N., Meenan J., et al. Vancomycin and ceftazidime bioactivities persist for at least 2 weeks in the lumen in ports. Simplifying treatment of port-associated bloodstream infections by using antibiotic lock technique. Antimicrob Agents Chemother 45 (2001) 1565-1567
46. Mermel L.A., Farr B.M., Sherertz R.J., et al. Guidelines for the management of intravascular catheter-related infections. Clin Infect Dis 32 (2001) 1249-1272
47. National Kidney Foundation. K/DOQI clinical practice guidelines for vascular access. Update 2000. Am J Kidney Dis 37 suppl 1 (2001) S137-S181
48. National Kidney Foundation: K/DOQI clinical practice guidelines for vascular access: Update 2006 (in press)
49. O'Grady N.P., Alexander M., Dellinger E.P., et al., Centers for Disease Control and Prevention. Guidelines for the prevention of intravascular catheter-related infections. MMWR Recomm Rep 51 (2002) 1-29
50. CDC. Recommendations for preventing the spread of vancomycin resistance. Recommendations of the Hospital Infection Control Practices Advisory Committee (HICPAC). MMWR 44 (1995)
51. Marr K.A., Sexton D.J., Conlon P.J., et al. Catheter-related bacteremia and outcome of attempted catheter salvage in patients undergoing hemodialysis. Ann Intern Med 127 (1997) 275-280
52. Shaffer D. Catheter-related sepsis complicating long-term, tunnelled central venous dialysis catheters. Management by guidewire exchange. Am J Kidney Dis 25 (1995) 593-596
53. Saad T.F. Bacteremia associated with tunneled, cuffed hemodialysis catheters. Am J Kidney Dis 34 (1999) 1114-1124
54. Beathard G.A. Management of bacteremia associated with tunneled-cuffed hemodialysis catheters. Am Soc Nephrol 10 (1999) 1045-1049
55. Capdevila J.A., Segarra A., Planes A.M., et al. Successful treatment of haemodialysis catheter-related sepsis without catheter removal. Nephrol Dial Transplant 8 (1993) 231-234
56. Poole C.V., Carolton D., Bimbo L., et al. Treatment of catheter-related bacteraemia with an antibiotic lock protocol. Effect of bacterial pathogen. Nephrol Dial Transplant 19 (2004) 1237-1244
57. Vardhan A., Davies J., Daryanani I., et al. Treatment of haemodialysis catheter-related infections. Nephrol Dial Transplant 17 (2002) 1149-1150
58. Allon M. Prophylaxis against dialysis catheter-related bacteremia with a novel antimicrobial lock solution. Clin Infect Dis 36 (2003) 1539-1544
59. Betjes M.G., and van Agteren M. Prevention of dialysis catheter-related sepsis with a citrate-taurolidine-containing lock solution. Nephrol Dial Transplant 19 (2004) 1546-1551
60. Kim S.H., Song K.I., Chang J.W., et al. Prevention of uncuffed hemodialysis catheter-related bacteremia using an antibiotic lock technique. A prospective, randomized clinical trial. Kidney Int 69 (2006) 161-164
61. Nori U., Fisher K.A., Osman Y., et al. Efficacy of antibiotic lock solutions in the prevention of hemodialysis catheter related bacteremia. (abstract). J Am Soc Nephrol 15 (2004) 60A
62. Mokrzycki M.H., and Singhal A. Cost-effectiveness of three strategies of managing tunnelled, cuffed haemodialysis catheters in clinically mild or asymptomatic bacteraemias. Nephrol Dial Transplant 17 (2002) 2196-2203
63. Balaban N., Gov Y., Bitler A., et al. Prevention of Staphylococcus aureus biofilm on dialysis catheters and adherence to human cells. Kidney Int 63 (2003) 340-345
64. Anthony T.U., and Rubin L.G. Stability of antibiotics used for antibiotic-lock treatment of infections of implantable venous devices (ports). Antimicrob Agents Chemother 43 (1999) 2074-2076